Cargando…
Influence of body mass index and periprostatic fat on rectal dosimetry in permanent seed prostate brachytherapy
PURPOSE: We examined the influence of body mass index (BMI) and body fat distribution on rectal dose in patients treated with permanent seed brachytherapy for localized prostate cancer. METHODS AND MATERIALS: We analyzed 213 patients treated with I(125) seed brachytherapy for localized prostate canc...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4002200/ https://www.ncbi.nlm.nih.gov/pubmed/24731303 http://dx.doi.org/10.1186/1748-717X-9-93 |
_version_ | 1782313786016792576 |
---|---|
author | Tiberi, David Gruszczynski, Nelson Meissner, Aliza Delouya, Guila Taussky, Daniel |
author_facet | Tiberi, David Gruszczynski, Nelson Meissner, Aliza Delouya, Guila Taussky, Daniel |
author_sort | Tiberi, David |
collection | PubMed |
description | PURPOSE: We examined the influence of body mass index (BMI) and body fat distribution on rectal dose in patients treated with permanent seed brachytherapy for localized prostate cancer. METHODS AND MATERIALS: We analyzed 213 patients treated with I(125) seed brachytherapy for localized prostate cancer. BMI and rectal dosimetry data for all patients were available. Data on visceral and subcutaneous fat distribution at the level of the iliac crest (n = 140) as well as the distribution of periprostatic and subcutaneous fat at the symphysis pubis level were obtained (n = 117). Fat distribution was manually contoured on CT on day 30 after brachytherapy. The correlation between BMI, fat distribution and rectal dose (R100 (in cc), R150 (cc), D2 (Gy)) was analyzed using the Spearman correlation coefficient. Differences in rectal dose between tertiles of body fat distribution were calculated using nonparametric tests. RESULTS: Periprostatic adipose was only weakly correlated with BMI (r = 0.0.245, p = 0.008) and only weakly correlated with the other fat measurements (r = 0.31-0.37, p < 0.001). On the other hand, BMI was correlated with all other fat measurements (≥0.58, p < 0.001). All the other fat measurements were strongly correlated with each other (r = 0.5-0.87, p < 0.001). Patients with an R100 of >1.3 cc (23% of patients) had less visceral fat (p = 0.004), less subcutaneous fat at the level of the iliac crest (p = 0.046) and a lower BMI (26.8 kg/m(2) vs. 28.5 kg/m(2), p = 0.02) than patients with an R100 of <1.3 cc. Results were very similar when comparing an R100 of >1.0 cc (34% of patients) across the tertiles. None of the tested linear regression models were predictive (max 12%) of dose to the rectum. CONCLUSION: Dose to the rectum is dependent on BMI and body fat distribution. Periprostatic fat does not influence rectal dose. Dose to the rectum remains difficult to predict and depends on many factors, one of which is body fat distribution. |
format | Online Article Text |
id | pubmed-4002200 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40022002014-04-29 Influence of body mass index and periprostatic fat on rectal dosimetry in permanent seed prostate brachytherapy Tiberi, David Gruszczynski, Nelson Meissner, Aliza Delouya, Guila Taussky, Daniel Radiat Oncol Research PURPOSE: We examined the influence of body mass index (BMI) and body fat distribution on rectal dose in patients treated with permanent seed brachytherapy for localized prostate cancer. METHODS AND MATERIALS: We analyzed 213 patients treated with I(125) seed brachytherapy for localized prostate cancer. BMI and rectal dosimetry data for all patients were available. Data on visceral and subcutaneous fat distribution at the level of the iliac crest (n = 140) as well as the distribution of periprostatic and subcutaneous fat at the symphysis pubis level were obtained (n = 117). Fat distribution was manually contoured on CT on day 30 after brachytherapy. The correlation between BMI, fat distribution and rectal dose (R100 (in cc), R150 (cc), D2 (Gy)) was analyzed using the Spearman correlation coefficient. Differences in rectal dose between tertiles of body fat distribution were calculated using nonparametric tests. RESULTS: Periprostatic adipose was only weakly correlated with BMI (r = 0.0.245, p = 0.008) and only weakly correlated with the other fat measurements (r = 0.31-0.37, p < 0.001). On the other hand, BMI was correlated with all other fat measurements (≥0.58, p < 0.001). All the other fat measurements were strongly correlated with each other (r = 0.5-0.87, p < 0.001). Patients with an R100 of >1.3 cc (23% of patients) had less visceral fat (p = 0.004), less subcutaneous fat at the level of the iliac crest (p = 0.046) and a lower BMI (26.8 kg/m(2) vs. 28.5 kg/m(2), p = 0.02) than patients with an R100 of <1.3 cc. Results were very similar when comparing an R100 of >1.0 cc (34% of patients) across the tertiles. None of the tested linear regression models were predictive (max 12%) of dose to the rectum. CONCLUSION: Dose to the rectum is dependent on BMI and body fat distribution. Periprostatic fat does not influence rectal dose. Dose to the rectum remains difficult to predict and depends on many factors, one of which is body fat distribution. BioMed Central 2014-04-14 /pmc/articles/PMC4002200/ /pubmed/24731303 http://dx.doi.org/10.1186/1748-717X-9-93 Text en Copyright © 2014 Tiberi et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Tiberi, David Gruszczynski, Nelson Meissner, Aliza Delouya, Guila Taussky, Daniel Influence of body mass index and periprostatic fat on rectal dosimetry in permanent seed prostate brachytherapy |
title | Influence of body mass index and periprostatic fat on rectal dosimetry in permanent seed prostate brachytherapy |
title_full | Influence of body mass index and periprostatic fat on rectal dosimetry in permanent seed prostate brachytherapy |
title_fullStr | Influence of body mass index and periprostatic fat on rectal dosimetry in permanent seed prostate brachytherapy |
title_full_unstemmed | Influence of body mass index and periprostatic fat on rectal dosimetry in permanent seed prostate brachytherapy |
title_short | Influence of body mass index and periprostatic fat on rectal dosimetry in permanent seed prostate brachytherapy |
title_sort | influence of body mass index and periprostatic fat on rectal dosimetry in permanent seed prostate brachytherapy |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4002200/ https://www.ncbi.nlm.nih.gov/pubmed/24731303 http://dx.doi.org/10.1186/1748-717X-9-93 |
work_keys_str_mv | AT tiberidavid influenceofbodymassindexandperiprostaticfatonrectaldosimetryinpermanentseedprostatebrachytherapy AT gruszczynskinelson influenceofbodymassindexandperiprostaticfatonrectaldosimetryinpermanentseedprostatebrachytherapy AT meissneraliza influenceofbodymassindexandperiprostaticfatonrectaldosimetryinpermanentseedprostatebrachytherapy AT delouyaguila influenceofbodymassindexandperiprostaticfatonrectaldosimetryinpermanentseedprostatebrachytherapy AT tausskydaniel influenceofbodymassindexandperiprostaticfatonrectaldosimetryinpermanentseedprostatebrachytherapy |